US 11091525
Method of refolding an interleukin-2 (IL-2) protein
granted A61KA61K38/2013A61K47/60
Quick answer
US patent 11091525 (Method of refolding an interleukin-2 (IL-2) protein) held by Nektar Therapeutics expires Mon Aug 12 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Nektar Therapeutics
- Grant date
- Tue Aug 17 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 12 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K38/2013, A61K47/60, A61P, A61P17/00